Canurta Therapeutics

Canurta Therapeutics is a biotechnology company headquartered in Toronto, Canada, specializing in cannabinoid-based therapeutics. Founded to harness the potential of rare cannabinoids for health innovation, it focuses on advancing medical solutions. Its business model emphasizes research-driven development, generating revenue through proprietary therapeutics and partnerships. Core operations include developing novel cannabinoid formulations, conducting clinical research, and creating health products targeting inflammation and chronic conditions, serving global pharmaceutical and wellness markets.

The company integrates Bitcoin into its treasury strategy, holding it as a reserve asset to diversify its financial portfolio and align with innovative financial trends. This approach reflects confidence in Bitcoin’s role as a hedge in corporate finance. Beyond treasury management, Canurta explores broader digital asset strategies, investigating blockchain applications to enhance supply chain transparency and secure clinical data, positioning itself at the intersection of biotech and decentralized technology.

Led by a management team with expertise in biotechnology and finance, Canurta maintains a growing industry presence through its pioneering cannabinoid research and collaborations with healthcare institutions. Its leadership drives a vision of blending scientific advancement with financial resilience, ensuring adaptability. By adopting Bitcoin and blockchain, Canurta secures long-term relevance in the evolving landscapes of health innovation and digital finance.

Date	BTC Balance	Change (BTC)	Cost Basis	Market Price	Stock Price
Aug 12, 2025	₿1.621	0.445	$167.1K	$118,702	—
Jun 1, 2025	₿1.176	0.173	—	$104,646	—
May 26, 2025	₿1.003	1.003	—	$109,051	—

Recent Developments